A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

Will present initial Phase 1C dose escalation data for vilastobart (XTX101), a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with ...

The Phase 2 TRANQUILITY trial, which evaluates quarterly and monthly subcutaneous dosing of pacibekitug in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease, is ...

Marlee Huskey wanted to deepen her studies in public health and learn more about her Native American culture. The Michigan ...

Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

Enrollment has been completed in two global Phase 3 studies of CASGEVY in children 5 to 11 years of ... CRISPR Therapeutics announced that it will present a poster from the Company’s ongoing Phase 1 ...

CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, today announced topline int ...

Insights from leading experts, such as a CEO and a Director of Business Operations ... We post comprehensive case studies on ...

The best business plan software makes it simple and easy to plan your business finances in order to present them to a bank or investors. The whole point of a business plan is that it allows you to ...

Interdisciplinary research and teaching on peace and security; international development; human rights and international law; and governance and civil society.

Context: Drug shortages have important consequences for patients and the health care system. International supply chains could favor countries with higher prices when there are production disruptions, ...